White label ELPA - ClinicalTrials.eu

Study on PET Tracers [18F]F-AraG and [89Zr]Zr-Df-Crefmirlimab for Evaluating T Cell Activation in Non-Small Cell Lung Cancer Patients

Not recruiting

4 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
- Nelarabine
- Zirconium (89Zr) Crefmirlimab Berdoxam
Study on Glenzocimab for Patients with Large Ischemic Stroke Eligible for Endovascular Therapy

Not recruiting

2 1 1
Investigated Drugs:
- Gadobutrol
- Glenzocimab
Study on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis

Not recruiting

2 1
Investigated Diseases:
- Colitis ulcerative
Investigated Drugs:
- Golimumab
- Guselkumab
+14
Study on the Effectiveness and Safety of RO7198457 and Pembrolizumab for Patients with Untreated Advanced Melanoma

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
- Autogene Cevumeran
- Pembrolizumab
Study on the Safety and Effectiveness of Human Alpha1-Proteinase Inhibitor for Preventing Graft-Versus-Host Disease in Patients Undergoing Hematopoietic Cell Transplant.

Not recruiting

4 1 1
Investigated Drugs:
- Human Alpha1-Proteinase Inhibitor
Study of Selpercatinib for Patients with Early-Stage RET Fusion-Positive Non-Small Cell Lung Cancer After Local Treatment

Not recruiting

3 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
- Selpercatinib
+8
Study of Trastuzumab Deruxtecan for Patients with HER2-Low Breast Cancer and New or Worsening Brain Metastases

Not recruiting

2 1 1
Investigated Diseases:
- HER2 negative breast cancer
- Metastases to central nervous system
Investigated Drugs:
- Trastuzumab Deruxtecan
Study of Gilteritinib and Chemotherapy for Children, Adolescents, and Young Adults with Relapsed or Refractory Acute Myeloid Leukemia with FLT3 Mutation

Not recruiting

1 1 1 1
Investigated Diseases:
- Acute myeloid leukaemia
Investigated Drugs:
Study comparing darolutamide versus hormone therapy (goserelin, leuprorelin, triptorelin, degarelix) in men with untreated hormone-sensitive prostate cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Hormone-dependent prostate cancer
Investigated Drugs:
Study of Acalabrutinib for Patients with Chronic Lymphocytic Leukemia

Not recruiting

3 1 1 1
Investigated Diseases:
- Chronic lymphocytic leukaemia
Investigated Drugs:
- Acalabrutinib
+3

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies